Search Results - "Dikkeschei, Bert D."

  • Showing 1 - 17 results of 17
Refine Results
  1. 1

    Prognostic value of troponin after elective percutaneous coronary intervention: A meta-analysis by Nienhuis, Mark B., Ottervanger, Jan Paul, Bilo, Henk J.G., Dikkeschei, Bert D., Zijlstra, Felix

    “…Background: Although the prognostic importance of troponin in patients with anacute coronary syndrome is clear, the significance of troponin elevation after…”
    Get full text
    Journal Article
  2. 2

    Alterations in plasma lecithin:cholesterol acyltransferase and myeloperoxidase in acute myocardial infarction: Implications for cardiac outcome by Dullaart, Robin P.F, Tietge, Uwe J.F, Kwakernaak, Arjan J, Dikkeschei, Bert D, Perton, Frank, Tio, René A

    Published in Atherosclerosis (01-05-2014)
    “…Abstract Background The cholesterol esterifying enzyme, lecithin:cholesterol acyltransferase (LCAT), plays a key role in HDL maturation and remodeling…”
    Get full text
    Journal Article
  3. 3

    Accuracy of handheld blood glucose meters at high altitude by de Mol, Pieter, Krabbe, Hans G, de Vries, Suzanna T, Fokkert, Marion J, Dikkeschei, Bert D, Rienks, Rienk, Bilo, Karin M, Bilo, Henk J G

    Published in PloS one (12-11-2010)
    “…Due to increasing numbers of people with diabetes taking part in extreme sports (e.g., high-altitude trekking), reliable handheld blood glucose meters (BGMs)…”
    Get full text
    Journal Article
  4. 4

    Statin and fibrate combination does not additionally lower plasma cholesteryl ester transfer in type 2 diabetes mellitus by de Vries, Rindert, Dikkeschei, Bert D, Sluiter, Wim J, Dallinga-Thie, Geesje M, van Tol, Arie, Dullaart, Robin P F

    Published in Clinical laboratory (Heidelberg) (01-01-2012)
    “…Plasma cholesteryl ester transfer (CET) from high density lipoproteins (HDL) to very low and low density lipoproteins (VLDL+LDL) may predict (subclinical)…”
    Get more information
    Journal Article
  5. 5

    Proprotein convertase subtilisin–kexin type 9 is elevated in proteinuric subjects: Relationship with lipoprotein response to antiproteinuric treatment by Kwakernaak, Arjan J, Lambert, Gilles, Slagman, Maartje C.J, Waanders, Femke, Laverman, Gozewijn D, Petrides, Francine, Dikkeschei, Bert D, Navis, Gerjan, Dullaart, Robin P.F

    Published in Atherosclerosis (01-02-2013)
    “…Abstract Objective LDL-receptor deficiency may provide a mechanism which contributes to atherogenic lipoprotein abnormalities in experimental nephrosis and in…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Metabolic Effects of High Altitude Trekking in Patients With Type 2 Diabetes by DE MOL, Peter, FOKKERT, Marion J, DE VRIES, Suzanna T, DE KONING, Eelco J. P, DIKKESCHEI, Bert D, GANS, Rijnold O. B, TACK, Cees J, BILO, HenkJ. G

    Published in Diabetes care (01-10-2012)
    “…Limited information is available regarding the metabolic effects of high altitude trekking in patients with type 2 diabetes. Thirteen individuals with type 2…”
    Get full text
    Journal Article
  8. 8

    Plasma Lp-PLA2 mass and apoB-lipoproteins that carry Lp-PLA2 decrease after sodium by Constantinides, Alexander, Kerstens, Michiel N., Dikkeschei, Bert D., van Pelt, L. Joost, Tellis, Constantinos C., Tselepis, Alexandros D., Dullaart, Robin P. F.

    Published in European journal of clinical investigation (01-11-2012)
    “…Eur J Clin Invest 2012; 42 (11): 1235–1243 Background  Lipoprotein‐associated phospholipase A2 (Lp‐PLA2) is a novel cardiovascular risk marker, which is…”
    Get full text
    Journal Article
  9. 9

    Plasma apolipoprotein M responses to statin and fibrate administration in type 2 diabetes mellitus by Kappelle, Paul J.W.H, Ahnström, Josefin, Dikkeschei, Bert D, de Vries, Rindert, Sluiter, Wim J, Wolffenbuttel, Bruce H.R, van Tol, Arie, Nielsen, Lars Bo, Dahlbäck, Björn, Dullaart, Robin P.F

    Published in Atherosclerosis (01-11-2010)
    “…Abstract Purpose Plasma apolipoprotein M (apoM) is potentially anti-atherogenic, and has been found to be associated positively with plasma total, LDL and HDL…”
    Get full text
    Journal Article
  10. 10

    Antioxidant role of plasma carotenoids in bronchopulmonary dysplasia in preterm infants by Vogelsang, Annelies, Lingen, Richard A. van, Slootstra, Janine, Dikkeschei, Bert D, Kollen, Boudewijn J, Schaafsma, Anne, Zoeren-Grobben, Diny van

    “…Oxidative stress is implicated in the pathogenesis of bronchopulmonary dysplasia (BPD) and consequently, it might be theorized that sufficient antioxidant…”
    Get full text
    Journal Article
  11. 11

    Elevated cholesteryl ester transfer protein activity in IDDM men who smoke. Possible factor for unfavorable lipoprotein profile by DULLAART, R. P. F, GROENER, J. E. M, DIKKESCHEI, B. D, ERKELENS, D. W, DOORENBOS, H

    Published in Diabetes care (01-04-1991)
    “…Elevated cholesteryl ester transfer protein activity in IDDM men who smoke. Possible factor for unfavorable lipoprotein profile. R P Dullaart , J E Groener , B…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Plasma Lp-PLA(2) mass and apoB-lipoproteins that carry Lp-PLA(2) decrease after sodium by Constantinides, Alexander, Kerstens, Michiel N, Dikkeschei, Bert D, van Pelt, L Joost, Tellis, Constantinos C, Tselepis, Alexandros D, Dullaart, Robin P F

    Published in European journal of clinical investigation (01-11-2012)
    “…Lipoprotein-associated phospholipase A(2) (Lp-PLA(2) ) is a novel cardiovascular risk marker, which is predominantly complexed to apolipoprotein (apo)…”
    Get full text
    Journal Article
  14. 14

    Role of elevated lecithin: Cholesterol acyltransferase and cholesteryl ester transfer protein activities in abnormal lipoproteins from proteinuric patients by Dullaart, Robin P.F., Gansevoort, Ron T., Dikkeschei, Bert D., de Zeeuw, Dick, de Jong, Paul E., van Tol, Arie

    Published in Kidney international (01-07-1993)
    “…Role of elevated lecithin: Cholesterol acyltransferase and cholesteryl ester transfer protein activities in abnormal lipoproteins from proteinuric patients…”
    Get full text
    Journal Article Conference Proceeding
  15. 15

    The effect of the initiation of renal replacement therapy on lipid profile and oxidative stress during the first 6 months of treatment by Diepeveen, Sabine H.A., Verhoeven, Gertie H.W.E., van der Palen, Job, Dikkeschei, Bert L.D., van Tits, Berry L.J., Kolsters, Geert, Offerman, Joop J.G., Bilo, Henk J.G., Stalenhoef, Anton F.H.

    Published in Clinica chimica acta (01-11-2005)
    “…Disturbed lipoproteins and increased oxidative stress are two of the “non-traditional” cardiovascular risk factors in chronic renal failure. There are very few…”
    Get full text
    Journal Article
  16. 16

    Oxidative stress in patients with end-stage renal disease prior to the start of renal replacement therapy by Diepeveen, Sabine H A, Verhoeven, Gertie H W E, van der Palen, Job, Dikkeschei, Bert L D, van Tits, Lambertus J, Kolsters, Geert, Offerman, Joop J G, Bilo, Henk J G, Stalenhoef, Anton F H

    Published in Nephron. Clinical practice (01-01-2004)
    “…In patients with end-stage renal disease (ESRD), cardiovascular complications are the main cause of death. Increased oxidative stress is one of the risk…”
    Get more information
    Journal Article
  17. 17

    Estradiol-dependent transcription initiation upstream from the chicken apoVLDLII gene coding for the very-low-density apolipoprotein II by Strijker, R, Blom van Assendelft, G, Dikkeschei, B D, Gruber, M, Ab, G

    Published in Gene (1986)
    “…We have investigated RNAs originating from the 5'-flanking region of the chicken very-low-density apolipoprotein II (apoVLDLII) gene. S1 nuclease mapping and…”
    Get more information
    Journal Article